The use of combination antiretroviral therapy (CART) in HIV‐infected patients has resulted in
a dramatic decline in AIDS‐related mortality. However, mortality due to non‐AIDS …

More than one-third of adults in the USA are obese and obesity-related disease accounts for
some of the leading causes of preventable death. Mid-life obesity may be a strong predictor …

Metabolic syndrome (MS), a group of interrelated risk factors for cardiovascular diseases
(CVD) and type 2 diabetes, has been increasingly reported among HIV-infected patients …

Use of highly active antiretroviral therapy (HAART) for the treatment of human
immunodeficiency virus (HIV) infection is associated with the development of cardiovascular …

OBJECTIVE: Persons with HIV infection develop metabolic abnormalities related to their
antiretroviral therapy and HIV infection itself. The objective of this study was to summarize …

HIV-associated lipodystrophy or lipoatrophy, unreported before the introduction of highly
active antiretroviral therapy (HAART), was first described in 1998, and has a prevalence …

Potent antiretroviral agents markedly suppress HIV and have dramatically improved the
clinical course, prognosis, and survival of HIV-infected patients. Unfortunately, highly active …

Highly active antiretroviral therapy (HAART) has had a significant impact on the natural
history of human immunodeficiency virus (HIV) infection, leading to a remarkable decrease …

Mortality rates in the HIV-infected patient population have decreased with the advent of
highly active antiretroviral therapy (HAART) for the treatment of AIDS. Due to the chronic …

The successful introduction of highly active antiretroviral therapy (HAART), a combination of
potent antiretroviral agents, including protease inhibitors, nucleoside reverse transcriptase …